Key data
| Regulation | Royal Decree 564/2026, of 8 July |
|---|---|
| Publication | 10 July 2026 |
| Entry into force | 10 July 2026 |
| Beneficiary | University Institute of Tropical Diseases and Public Health of the Canary Islands (IUETSPC), attached to the University of La Laguna |
| Total amount | €450,000 |
| Modality | Direct grant (art. 22.2.c) General Law on Grants) |
| Category | Grants and Subsidies |
| Reference framework | Strategic Plan for Grants 2024-2026 of the Ministry of Health / International Health Regulations (WHO) |
| Strategic networks | RE-LAB and CIBERINFEC |
The State allocates €450,000 to the University Institute of Tropical Diseases and Public Health of the Canary Islands (IUETSPC) through Royal Decree 564/2026, of 8 July, published in the BOE on 10 July 2026. The grant is structured as a direct grant under article 22.2.c) of the Law 38/2003, General Law on Grants, which allows this modality when the activity has a singular and exceptional character of public interest.
The regulation responds to the Strategic Plan for Grants 2024-2026 of the Ministry of Health and the International Health Regulations of the WHO, and strengthens the institute's position within two top-level national strategic networks: RE-LAB and CIBERINFEC.
What does this regulation establish?
RD 564/2026 regulates the direct grant of a subsidy to IUETSPC, attached to the University of La Laguna, to finance three major lines of activity:
| Financed activity line | Description |
|---|---|
| Research personnel | Hiring and maintenance of researchers specializing in tropical diseases and public health |
| Equipment and laboratories | Renewal of scientific equipment and laboratory facilities |
| Entomological surveillance | Vector control and monitoring activities, with special focus on Aedes aegypti and Aedes albopictus |
The choice of direct grant modality (instead of competitive bidding) is justified by the singular and exceptional nature of IUETSPC's activity, which is the only Spanish organization specialized in tropical diseases with a presence in the Canary Islands, a territory of special risk due to its geographical position between Europe, Africa and America.
The institute is part of RE-LAB (Biological Alert Laboratory Network) and CIBERINFEC (Biomedical Research Network Center for Infectious Diseases), which strengthens the justification of the public interest of the grant.
Economic and operational impact
The direct economic impact of this regulation is concentrated entirely on IUETSPC. It does not generate administrative burdens, obligations or costs for third parties, whether private companies, self-employed workers or other administrations.
From the perspective of the research and public health sector, the €450,000 will allow:
- Maintain and expand specialized research personnel, reducing precariousness in a highly specialized scientific field.
- Modernize laboratories and equipment, which increases diagnostic capacity and response capability in case of tropical disease outbreaks.
- Strengthen active surveillance of vector mosquitoes (Aedes aegypti and Aedes albopictus), key to preventing dengue, zika and chikungunya fever in Spanish territory.
The regulation does not include comparative data with previous grants to the same beneficiary, so it is not possible to establish a comparison of amounts between fiscal years.
Who does it affect?
- Directly: University Institute of Tropical Diseases and Public Health of the Canary Islands (IUETSPC), attached to the University of La Laguna.
- Indirectly: Research and technical personnel of IUETSPC (hiring and job maintenance).
- Institutional: Ministry of Health, as the granting body and responsible for the Strategic Plan for Grants 2024-2026.
- Does not affect: Private companies, self-employed workers, other universities or other public administrations. It does not generate obligations or burdens for third parties.
Practical example
IUETSPC receives €450,000 in direct state financing. Let's suppose the institute distributes these funds among its three priority lines in the following indicative manner, consistent with the purposes described in RD 564/2026:
| Destination | Use |
|---|---|
| Hiring and maintenance of research personnel | Researchers specializing in vectors and tropical diseases |
| Renewal of equipment and laboratories | Update of scientific instruments and improvement of facilities |
| Entomological surveillance | Monitoring of Aedes aegypti and Aedes albopictus populations in the Canary Islands |
This scheme allows IUETSPC to maintain its activity within RE-LAB and CIBERINFEC, complying with commitments derived from the WHO International Health Regulations and strengthening early warning capacity against possible outbreaks in the Canary Islands archipelago.
What should companies do now?
This regulation does not generate obligations for companies or self-employed workers. However, if your organization operates in the field of biomedical research, public health or health surveillance in the Canary Islands, these are the relevant actions:
- If you are IUETSPC: Verify that the grant is recorded in your accounting in accordance with public grant regulations (Law 38/2003) and prepare the spending justification mechanisms required by the Ministry of Health.
- If you are a supplier of scientific or laboratory equipment: IUETSPC will have funds for equipment renewal. Contact the institute to learn about its procurement or purchase needs.
- If you are a researcher or university manager: Consult with the University of La Laguna the conditions for hiring research personnel that will be activated with this financing.
- If you manage other research entities: Analyze whether your activity could justify a similar direct grant under art. 22.2.c) of the General Law on Grants, especially if you are part of national strategic networks such as CIBERINFEC or RE-LAB.
Frequently asked questions
What will the €450,000 grant to IUETSPC be used for?
The funds will be allocated to three lines: hiring and maintenance of research personnel, renewal of equipment and laboratories, and entomological surveillance activities against vectors such as Aedes aegypti and Aedes albopictus, as established by RD 564/2026.
Why is this grant awarded directly and not through competitive bidding?
Article 22.2.c) of the General Law on Grants allows direct granting when the activity has a singular and exceptional character of public interest. IUETSPC is the only Spanish organization specialized in tropical diseases with a presence in the Canary Islands, which justifies this exceptional modality.
When does RD 564/2026 enter into force?
Royal Decree 564/2026 entered into force on the same day as its publication in the BOE: 10 July 2026.
Does this grant generate obligations or burdens for private companies?
No. RD 564/2026 does not generate administrative burdens for third parties. Its direct economic impact is limited exclusively to the designated beneficiary, IUETSPC, attached to the University of La Laguna.
What national strategic networks does IUETSPC integrate?
IUETSPC is part of RE-LAB (Biological Alert Laboratory Network) and CIBERINFEC (Biomedical Research Network Center for Infectious Diseases), which strengthens the justification of the public interest of the grant.
Official source
Consult complete regulation in official source
Notice: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2026-15031